Ethic Inc. Rapt Therapeutics, Inc. Transaction History
Ethic Inc.
- $4.83 Billion
- Q4 2024
A detailed history of Ethic Inc. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Ethic Inc. holds 11,794 shares of RAPT stock, worth $14,152. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,794Holding current value
$14,152% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RAPT
# of Institutions
100Shares Held
124MCall Options Held
246KPut Options Held
69.6K-
Medicxi Ventures Management (Jersey) LTD22.4MShares$26.8 Million7.76% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA13.1MShares$15.8 Million3.39% of portfolio
-
Orbimed Advisors LLC San Diego, CA13.1MShares$15.8 Million0.56% of portfolio
-
Foresite Capital Management Vi LLC Larkspur, CA12.5MShares$15 Million8.8% of portfolio
-
Rtw Investments, LP New York, NY11.8MShares$14.1 Million0.3% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $35.6M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...